Lumbar Degenerative Disc Disease Market Thrives on Regenerative Spine Therapies & Japan's Robotic Surgery Growth | Sorrento Therapeutics, SpineThera, Eliem Therapeutics, Scilex Holding

Global Lumbar Degenerative Disc Disease Market reached US$ 12.1 billion in 2022 and is expected to reach US$ 21.3 billion by 2030, growing with a CAGR of 7.4% during the forecast period 2023-2030.

Lumbar Degenerative Disc Disease Market Report by DataM Intelligence offers a detailed assessment of the global spine devices and therapeutic landscape, highlighting market size, key players, and critical growth drivers. With the rise of motion-preserving implants, biologic/regenerative approaches, and minimally invasive endoscopic procedures, the report delivers strategic insights for stakeholders from 2025 to 2033. In 2025, implant innovation and minimally invasive surgical techniques accelerated, U.S. spinal implant advances and Japan's growing MIS implant programs (plus broader adoption of navigation and endoscopic fusion) are driving a renewed device cycle for lumbar DDD treatment.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/research-report/lumbar-degenerative-disc-disease-market?ophp

Lumbar Degenerative Disc Disease Market Competitors Overview:

Sorrento Therapeutics, SpineThera, Eliem Therapeutics, Scilex Holding, Sinfonia Biotherapeutics, Seikagaku Corporation, Kolon life Science, Vita Sciences, Aurobindo Pharma, and Neurotech among others.

Important Industry Updates:

In January 2023, DiscGenics, Inc., a clinical-stage biopharmaceutical corporation concentrated on designing cell-based regenerative therapies that relieve pain and repair function in individuals with degenerative conditions of the spine, obtained the U.S. Food and Drug Administration (FDA) Regenerative Medicine Advanced Therapy (RMAT) designation to Injectable Disc Cell Therapy (IDCT or rebonuputemcel), an injectable, allogeneic discogenic progenitor cell therapy to treat symptomatic lumbar degenerative disc disease (DDD).

In July 2023, Alpha Healthcare Acquisition Corp. III ("ALPA"), a special purpose acquisition corporation merged the business (the "Business Combination") with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform corporation producing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications.

Methodology and Scope

The Lumbar Degenerative Disc Disease Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lumbar-degenerative-disc-disease-market?ophp

Lumbar Degenerative Disc Disease Market Segments Overview:

∎ By Treatment Type
Drug Treatment
Biologics
Other

∎ By Route of Administration
Oral
Injectables
Other

∎ By End-User
Hospitals
Specialty Clinics
Academic Research Centers
Others

Regional Overview for Lumbar Degenerative Disc Disease Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=lumbar-degenerative-disc-disease-market

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Lumbar Degenerative Disc Disease market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Lumbar Degenerative Disc Disease market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.